Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lipoteichoic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN119019478B reveals novel glycosylation method for Type II Lipoteichoic Acid. Enables scalable production and cost reduction for pharmaceutical intermediates.
Patent CN119019478A reveals a novel glycosylation method for Type II lipoteichoic acid, offering high conversion and scalable manufacturing for immunological research.